Boehringer says R&D pipeline is the best in its long history

[cafead]

via Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its 139-year history.

article source